The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Haemophilus Influenzae Type B Vaccine Market Research Report 2025

Global Haemophilus Influenzae Type B Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1599667

No of Pages : 83

Ask Your Query

Synopsis

Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.

The global Haemophilus Influenzae Type B Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Haemophilus Influenzae Type B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemophilus Influenzae Type B Vaccine.

Report Scope

The Haemophilus Influenzae Type B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Haemophilus Influenzae Type B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Haemophilus Influenzae Type B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Novartis
  • Merck
  • Sanofi
  • GlaxoSmithKline
  • Takeda Pharmaceuticals Company
  • Walvax Biotechnology
  • Lanzhou Institute of Biologica
  • Immunize BC

Segment by Type

  • Liquid Monovalent HIB
  • Liquid Combination HIB
  • Lyophilized Monovalent HIB
  • Lyophilized Combination HIB

Segment by Application

  • Hospital
  • Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Academic Institutions
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Haemophilus Influenzae Type B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Haemophilus Influenzae Type B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Haemophilus Influenzae Type B Vaccine Market Overview
1.1 Product Overview and Scope of Haemophilus Influenzae Type B Vaccine
1.2 Haemophilus Influenzae Type B Vaccine Segment by Type
1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Liquid Monovalent HIB
1.2.3 Liquid Combination HIB
1.2.4 Lyophilized Monovalent HIB
1.2.5 Lyophilized Combination HIB
1.3 Haemophilus Influenzae Type B Vaccine Segment by Application
1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Global Haemophilus Influenzae Type B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Haemophilus Influenzae Type B Vaccine Revenue 2019-2030
1.4.2 Global Haemophilus Influenzae Type B Vaccine Sales 2019-2030
1.4.3 Global Haemophilus Influenzae Type B Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Haemophilus Influenzae Type B Vaccine Market Competition by Manufacturers
2.1 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Haemophilus Influenzae Type B Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Haemophilus Influenzae Type B Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Product Type & Application
2.7 Haemophilus Influenzae Type B Vaccine Market Competitive Situation and Trends
2.7.1 Haemophilus Influenzae Type B Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue
2.7.3 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Haemophilus Influenzae Type B Vaccine Retrospective Market Scenario by Region
3.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Haemophilus Influenzae Type B Vaccine Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2019-2030
3.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2019-2024
3.2.2 Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2025-2030
3.3 Global Haemophilus Influenzae Type B Vaccine Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2019-2030
3.3.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2019-2024
3.3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2025-2030
3.4 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.4.1 North America Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
3.4.3 North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.5.1 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
3.5.3 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.7.1 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2030)
4.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030)
4.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2030)
4.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030)
4.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2030)
5.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024)
5.1.2 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030)
5.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2030)
5.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024)
5.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030)
5.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Haemophilus Influenzae Type B Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Haemophilus Influenzae Type B Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Takeda Pharmaceuticals Company
6.5.1 Takeda Pharmaceuticals Company Corporation Information
6.5.2 Takeda Pharmaceuticals Company Description and Business Overview
6.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio
6.5.5 Takeda Pharmaceuticals Company Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Lanzhou Institute of Biologica
6.6.1 Lanzhou Institute of Biologica Corporation Information
6.6.2 Lanzhou Institute of Biologica Description and Business Overview
6.6.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio
6.7.5 Lanzhou Institute of Biologica Recent Developments/Updates
6.8 Immunize BC
6.8.1 Immunize BC Corporation Information
6.8.2 Immunize BC Description and Business Overview
6.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio
6.8.5 Immunize BC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Haemophilus Influenzae Type B Vaccine Industry Chain Analysis
7.2 Haemophilus Influenzae Type B Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Haemophilus Influenzae Type B Vaccine Production Mode & Process
7.4 Haemophilus Influenzae Type B Vaccine Sales and Marketing
7.4.1 Haemophilus Influenzae Type B Vaccine Sales Channels
7.4.2 Haemophilus Influenzae Type B Vaccine Distributors
7.5 Haemophilus Influenzae Type B Vaccine Customers
8 Haemophilus Influenzae Type B Vaccine Market Dynamics
8.1 Haemophilus Influenzae Type B Vaccine Industry Trends
8.2 Haemophilus Influenzae Type B Vaccine Market Drivers
8.3 Haemophilus Influenzae Type B Vaccine Market Challenges
8.4 Haemophilus Influenzae Type B Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock